Advances in Molecular and Clinical Subtyping of Breast Cancer and Their Implications for Therapy

被引：30

作者：

Cadoo, Karen A. ^{[1
]}

Traina, Tiffany A. ^{[2
]}

King, Tari A. ^{[3
]}

机构：

[1] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10065 USA

[2] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med,Breast Canc Med Serv, New York, NY 10065 USA

[3] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Surg,Breast Serv, New York, NY 10065 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2013年 / 22卷 / 04期

关键词：

Breast cancer; Intrinsic subtypes; Endocrine therapy; HER2; positive; Triple negative; Resistance; RANDOMIZED PHASE-II; GENE-EXPRESSION; ENDOCRINE THERAPY; TRASTUZUMAB RESISTANCE; ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN; TUMOR SUBTYPES; OPEN-LABEL; RECEPTOR; TAMOXIFEN;

D O I：

10.1016/j.soc.2013.06.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The identification of the intrinsic molecular subtypes of breast cancer has enhanced our understanding of tumor biology, informing therapeutic targets, and clinical trial design. This article reviews the intrinsic classification system and the clinically defined subtypes of breast cancer. We review the molecular drivers of each subtype and discuss implications for prognosis, clinical management, and future directions.

引用

页码：823 / +

页数：19

共 93 条

[11] A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer [J].

Berns, Katrien ;

Horlings, Hugo M. ;

Hennessy, Bryan T. ;

Madiredjo, Mandy ;

Hijmans, E. Marielle ;

Beelen, Karin ;

Linn, Sabine C. ;

Gonzalez-Angulo, Ana Maria ;

Stemke-Hale, Katherine ;

Hauptmann, Michael ;

Beijersbergen, Roderick L. ;

Mills, Gordon B. ;

de Vijver, Marc J. van ;

Bernards, Rene .

CANCER CELL, 2007, 12 (04) :395-402

[12]

Bhattacharyya GS, 2011, EUR MULT CANC C STOC

[13] Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer [J].

Blackwell, Kimberly L. ;

Burstein, Harold J. ;

Storniolo, Anna Maria ;

Rugo, Hope ;

Sledge, George ;

Koehler, Maria ;

Ellis, Catherine ;

Casey, Michelle ;

Vukelja, Svetislava ;

Bischoff, Joachim ;

Baselga, Jose ;

O'Shaughnessy, Joyce .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1124-1130

[14] Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer [J].

Buyse, Marc ;

Loi, Sherene ;

van't Veer, Laura ;

Viale, Giuseppe ;

Delorenzi, Mauro ;

Glas, Annuska M. ;

d'Assignies, Mahasti Saghatchian ;

Bergh, Jonas ;

Lidereau, Rosette ;

Ellis, Paul ;

Harris, Adrian ;

Bogaerts, Jan ;

Therasse, Patrick ;

Floore, Arno ;

Amakrane, Mohamed ;

Piette, Fanny ;

Rutgers, Emiel ;

Sotiriou, Christos ;

Cardoso, Fatima ;

Piccart, Martine J. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (17) :1183-1192

[15] Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy [J].

Byrski, Tomasz ;

Gronwald, Jacek ;

Huzarski, Tomasz ;

Grzybowska, Ewa ;

Budryk, Magdalena ;

Stawicka, Malgorzata ;

Mierzwa, Tomasz ;

Szwiec, Marek ;

Wisniowski, Rafal ;

Siolek, Monika ;

Dent, Rebecca ;

Lubinski, Jan ;

Narod, Steven .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) :375-379

[16] The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes [J].

Carey, Lisa A. ;

Dees, E. Claire ;

Sawyer, Lynda ;

Gatti, Lisa ;

Moore, Dominic T. ;

Collichio, Frances ;

Ollila, David W. ;

Sartor, Carolyn I. ;

Graham, Mark L. ;

Perou, Charles M. .

CLINICAL CANCER RESEARCH, 2007, 13 (08) :2329-2334

[17] Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].

Carey, Lisa A. ;

Perou, Charles M. ;

Livasy, Chad A. ;

Dressler, Lynn G. ;

Cowan, David ;

Conway, Kathleen ;

Karaca, Gamze ;

Troester, Melissa A. ;

Tse, Chiu Kit ;

Edmiston, Sharon ;

Deming, Sandra L. ;

Geradts, Joseph ;

Cheang, Maggie C. U. ;

Nielsen, Torsten O. ;

Moorman, Patricia G. ;

Earp, H. Shelton ;

Millikan, Robert C. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502

[18] TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer [J].

Carey, Lisa A. ;

Rugo, Hope S. ;

Marcom, P. Kelly ;

Mayer, Erica L. ;

Esteva, Francisco J. ;

Ma, Cynthia X. ;

Liu, Minetta C. ;

Storniolo, Anna Maria ;

Rimawi, Mothaffar F. ;

Forero-Torres, Andres ;

Wolff, Antonio C. ;

Hobday, Timothy J. ;

Ivanova, Anastasia ;

Chiu, Wing-Keung ;

Ferraro, Madlyn ;

Burrows, Emily ;

Bernard, Philip S. ;

Hoadley, Katherine A. ;

Perou, Charles M. ;

Winer, Eric P. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2615-2623

[19]

CH Ng, 2012, ESMO 2012 C VIENN SE

[20] Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer [J].

Chandarlapaty, Sarat ;

Sakr, Rita A. ;

Giri, Dilip ;

Patil, Sujata ;

Heguy, Adriana ;

Morrow, Monica ;

Modi, Shanu ;

Norton, Larry ;

Rosen, Neal ;

Hudis, Clifford ;

King, Tari A. .

CLINICAL CANCER RESEARCH, 2012, 18 (24) :6784-6791

← 1 2 3 4 5 6 7 8 9 10 →